Edition:
United States

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

18.35USD
7 Dec 2018
Change (% chg)

$-0.14 (-0.76%)
Prev Close
$18.49
Open
$18.56
Day's High
$18.76
Day's Low
$18.32
Volume
92,188
Avg. Vol
79,175
52-wk High
$19.82
52-wk Low
$13.55

Select another date:

Fri, Nov 30 2018

FDA approves Meridian Bioscience's test for herpes in newborns

The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

UPDATE 1-FDA approves Meridian Bioscience's test for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday the first test - a diagnostic from Meridian Bioscience Inc - to help detect a type of herpes virus in newborns.

FDA approves Meridian Bioscience's diagnostic for herpes in newborns

Nov 30 The U.S. Food and Drug Administration approved on Friday a diagnostic test from Meridian Bioscience Inc as the first tool to help detect a type of herpes virus in newborns.

Select another date: